Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 9/20 | 1.00 |
| ▸ | HTR1D | P28221 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6546383 | 1.00 | HTR1A (1.00) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL8442654 | 0.89 | HTR1A (0.80) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL9004457 | 0.89 | HTR1A (0.80) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL8442968 | 0.88 | HTR1A (0.78) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL7453383 | 0.88 | HTR1A (0.78) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL7458206 | 0.88 | HTR1A (0.78) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL7460894 | 0.86 | HTR1A (0.75) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL8762947 | 0.86 | HTR1A (0.75) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL8444529 | 0.86 | HTR1A (0.75) | HTR1AHTR1DHTR2BALDH1A1LMNA | |
| SCHEMBL7452105 | 0.85 | HTR1A (0.74) | HTR1AHTR1DHTR2BALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0877612-B1 | USE OF PIPERAZINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS | WYETH JOHN & BROTHER LTD (GB) | 2000-08-16 | — | — | EP | claimed |
| EP-0877612-A1 | USE OF PIPERAZINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS | JOHN WYETH & BROTHER LIMITED (GB) | 1998-11-18 | — | — | EP | claimed |
| WO-1994009780-A1 | USE OF PIPERAZINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS | JOHN WYETH & BROTHER LIMITED (GB) | 1994-05-11 | — | — | WO | claimed |
| EP-0877612-B1 | USE OF PIPERAZINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS | WYETH JOHN & BROTHER LTD (GB) | 2000-08-16 | — | — | EP | disclosed |
| EP-0664799-B1 | AMIDE DERIVATIVES | WYETH JOHN & BROTHER LTD (GB) | 1999-07-14 | — | — | EP | disclosed |
| EP-0877612-A1 | USE OF PIPERAZINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS | JOHN WYETH & BROTHER LIMITED (GB) | 1998-11-18 | — | — | EP | disclosed |
| US-5637701-A | Process for preparing optically active amide derivatives | JOHN WYETH & BROTHER, LIMITED (GB) | 1997-06-10 | — | — | US | disclosed |
| WO-1994009780-A1 | USE OF PIPERAZINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS | JOHN WYETH & BROTHER LIMITED (GB) | 1994-05-11 | — | — | WO | disclosed |